EDUCATION AND TRAINING
Postdoctoral Fellow, National Institute on Aging, Baltimore, MD, 1993-1994.
Cardiology Fellow, Brigham and Women's Hospital, Boston, MA, 1994-1997.
Intern and Resident, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, 1991-1993.
M.D. (with Honors), University of Rochester Medical Center, 1991.
Ph.D., Biochemistry, University of Rochester, 1988.
A.B., Biochemical Sciences, Princeton University, 1983.
Michael T. Chin M.D., Ph.D., F.A.C.C., F.A.H.A.
Associate Professor, University of Washington School of Medicine
Harold T. Dodge/John L. Locke Endowed Chair of Cardiovascular Medicine
850 Republican Street
Seattle, WA 98109
(206) 598-4300 (at UW Medical Center)
Office: (206) 616-8880
Fax: (206) 616-4082
American Board of Internal Medicine, 1994-2004.
American Board of Internal Medicine, Subspecialty in Cardiovascular Disease, 1997-present.
AREAS OF CLINICAL EXPERTISE
Role of Smooth Muscle Cells in Occlusive Vascular Disease
Regulation of Cardiac Hypertrophy and Heart Failure
CURRENT RESEARCH INTERESTS
Use of Embryonic Stem Cells for Cardiac Regeneration
Regulation of cardiac hypertrophy and heart failure
(For more information see http://depts.washington.edu/somslu/labs/chin.html.)
Genetics of congenital cardiovascular abnormalities
Role of smooth muscle cells in occlusive vascular disease
Walter R. Bloor Award, University of Rochester, 1989.
Wallace O. Fenn Award, University of Rochester, 1989.
Alpha Omega Alpha Medical Honor Society, 1990.
Robert Kates Award, University of Rochester, 1991.
Class of 1976 Prize, University of Rochester, 1991.
Research Award for Clinical Trainees, National Institutes of Health, 1992.
1st Prize, American College of Cardiology Young Investigator Competition, 2000.
2nd Prize, New England Cardiovascular Research Competition, 2000.
1st Prize, AstraZeneca Cardiovascular Young Investigator's Forum, 2002.
Finalist, Katz Young Investigator Competition, American Heart Association, 2002.
Fellow, American College of Cardiology, 2002.
Fellow, American Heart Association, 2004.
Harold T. Dodge/John L. Locke Endowed Chair in Cardiovascular Medicine, 2006.
Sun, J, Kamei, CN, Layne, MD, Jain, MK, Liao, JK, Lee, M-E and Chin, MT, Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2, J. Biol. Chem. 276:18591-18596, 2001.
Sakata, Y, Kamei, CN, Nakagami, H, Bronson, R, Liao, JK and Chin, MT, Ventricular septal defects and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2, Proc. Natl. Acad. Sci. USA 99:16197-16202, 2002.
Chin, MT, Balke, CW, Webb, RC, Mentoring concerns in basic cardiovascular science, in "Mentoring Handbook" (2003), American Heart Assn., Dallas, TX, pp. 23-46.
Sakata, Y, Xiang F, Chen, Z, Kiriyama, Y, Kamei, CN, Simon, DI and Chin, MT, Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro, Arterioscler. Thromb. Vasc. Biol. 24:2069-2074, 2004.
Sakata, Y, Koibuchi, N, Xiang, F, Youngblood, JM, Kamei, CN and Chin, MT, The Spectrum of Cardiovascular Anomalies in CHF1/Hey2 Deficient Mice Reveals Roles in Endocardial Cushion, Myocardial and Vascular Maturation, J. Mol. Cell. Cardiol. 40:267-273, 2006.
Xiang, F, Sakata, Y, Cui, L, Youngblood, JM, Nakagami, H, Liao, JK, Liao, R and Chin, MT, Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4, Am. J. Physiol. Heart Circ. Physiol. 290:H1997-H2006, 2006.